ERK1/2 Antibody (SP05-09), Novus Biologicals™

ERK1/2

Monoclonal

1 mg/mL

Western Blot 1:1000-1:5000, Flow Cytometry 1:50-1:100, Immunohistochemistry, Immunocytochemistry/Immunofluorescence 1:100-1:500, Immunoprecipitation, Immunohistochemistry-Paraffin 1:50-1:200

EC 2.7.11, ERK-1, ERK1p44-MAPK, ERT2, Extracellular signal-regulated kinase 1, extracellular signal-related kinase 1, HS44KDAP, HUMKER1A, Insulin-stimulated MAP2 kinase, MAP kinase 1, MAP kinase 3, MAP kinase isoform p44, MAPK 1, MAPK 3, MGC20180, Microtubule-associated protein 2 kinase, Mitogen-activated protein kinase 1, mitogen-activated protein kinase 3, p44erk1, p44-ERK1, p44mapk, PRKM3EC 2.7.11.24

Rabbit

Protein A purified

Alzheimers Research, Angiogenesis, Apoptosis, Breast Cancer, Cancer, Caspases, Cell Cycle and Replication, Diabetes Research, Hypoxia, MAP Kinase Signaling, mTOR Pathway, Neurodegeneration, Phospho Specific, Protein Kinase, Signal Transduction

5595

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

IgG

Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin)

SP05-09

Unconjugated

TBS (pH7.4), 0.05% BSA, 40% Glycerol with 0.05% Sodium Azide

MAPK3

Synthetic peptide within N-terminal human ERK1/2. (SwissProt: P27361 Human; SwissProt: Q63844 Mouse)

100 μL

Primary

Human, Mouse

Purified